Topic: Abbott Labs

Major news networks provided varying accounts of Bob Woodward's claims regarding Trump and Putin. While Kamala Harris referred to "test kits" in her interviews, Woodward's book specifically mentions "Abbott point-of-care" testing machines. Critics point out that NBC and other outlets failed to clarify this distinction, potentially misleading the public about the nature of the equipment sent to Russia in 2020.

Poison control centers in Ohio and across the U.S. are warning about sodium azide, a toxic liquid found in some at-home COVID-19 testing kits. Accidental exposures have been reported in children and adults who misused the kits, sometimes mistaking the liquid for nasal spray. Sodium azide was historically used in automotive airbags and can be harmful if ingested or touched.

A severe baby formula shortage in the United States was triggered by the FDA-mandated closure of an Abbott Labs plant in Sturgis, Michigan. While the government cited infant deaths from *Chronobacter* bacteria, Abbott Labs claims genetic sequencing proved their facility was not the source of the infection. The shortage is exacerbated by WIC program contracts and high tariffs on Canadian dairy imports.

Reports suggest the WHO initially parroted Chinese claims that there was no evidence of human-to-human transmission in Wuhan. President Trump described his personal experience with coronavirus testing, contrasting the "unpleasant" initial deep-nasal swab with the newer, faster Abbott Labs test. Trump's rhetoric toward China shifted as the global impact of the virus became more apparent.

The hosts discuss the transition from vaccine mandates to mandatory testing as a means of social control. They predict the rise of "Freedom Passports" based on proctored home tests from companies like Abbott Labs, potentially involving new testing technology acquired by Bill Gates and George Soros.

ABC News is criticized for promoting "safety rules" for Thanksgiving that include masking between bites and requiring guests to take rapid tests. The hosts suggest the segment functions as a native advertisement for Abbott Labs' BinaxNOW tests. They discuss the cultural shift toward home testing and its potential integration into travel protocols.

Jen Psaki is seen promoting at-home COVID-19 tests from Walmart, which she claims to use herself. The hosts discuss the shift toward home testing and the lack of government oversight for these specific kits. They also mention new tests that plug into smartphones to transmit results directly to the CDC, questioning the privacy implications.

Travelers at Dulles International Airport and other U.S. hubs face inconsistent international COVID-19 entry requirements, including mandatory temperature checks and expensive nasal swabs. Rapid same-day testing can cost up to $250 per person, creating a significant financial burden for families. Airlines are increasingly integrating digital health apps and self-test kits from companies like Abbott Labs to manage shifting global regulations.

Admiral Brett Girard and the Department of Health and Human Services are rolling out millions of Abbott BinaxNOW rapid antigen tests to schools and nursing homes. These tests provide results in 15 minutes but are criticized for being tied to digital health apps that could eventually act as a "green light" for public access. The shift toward antigen testing is predicted to lower official case rates compared to high-cycle PCR testing.

The FDA and WHO are identified as the entities setting the cycle thresholds for PCR tests, with current recommendations reaching as high as 45 cycles. High cycle counts are blamed for creating false positives, while companies like Abbott Labs are noted for seeing double-digit stock growth linked to the rollout of testing apps and digital health passes.

Nursing homes in Alabama are reportedly being pushed to use the Navica app from Abbott Labs to track staff and patient COVID-19 results. The app generates a temporary mobile pass with a barcode and expiration date, mirroring the health passport systems being implemented internationally.

Reports from nursing home operators reveal a crisis involving mandatory COVID-19 testing and high rates of false positives from Becton Dickinson and Abbott Labs antigen tests. Facilities are being forced into expensive lockdowns based on single positive results, costing upwards of $40,000 per week. The hosts argue that the testing industry is profiting from flawed data while isolating the elderly.

Abbott Labs, based north of Chicago, plans to produce 50 million rapid COVID-19 test kits per month. The company intends to release a smartphone application that provides a red or green status based on test results. This initiative is described as a private-sector attempt to create a universal health passport for access to venues and travel.

President Trump describes the physical discomfort of the initial deep-nasal COVID-19 test, comparing it to a probe going "under the eye." He contrasts this with the newer, less invasive Abbott Labs test that provides results in minutes. The hosts criticize the media for failing to explain the logistical and physical realities of mass testing to the public.

The pharmaceutical product Marinol, a synthetic form of THC known as dronabinol, is identified as a competitor to natural marijuana. Solvay Pharmaceuticals, the maker of Marinol, was recently acquired by Abbott Labs. The segment suggests that the government's continued crackdown on natural marijuana is intended to protect the market share of patented synthetic alternatives.